In a previous blog post, we introduced you to the body’s endocannabinoid system which is often referred to as ECS. We explained the role your ECS plays in your overall wellness and outlined how CBD engages with the ECS to promote well-being.
Your skin has its very own endocannabinoid system complete with its own receptors tasked with homeostasis. Imbalance in the skin’s endocannabinoid system can result in pathological skin conditions such as: acne, dermatitis, psoriasis and seborrhea to name but a few.
Research in 2013 showed that phytocannabinoids such as CBD are a transcriptional repressor and can control cell proliferation and differentiation. “This indicates that they (especially cannabidiol) have the potential to be lead compounds for the development of novel therapeutics for skin diseases” ¹
Skin issues are pesky at best and this research is super news.
Topical Application of CBD
Applying CBD topically is an effective method for introducing cannabinoids to the skin’s ECS because the application is focused and allows for immediate absorption into the ECS. In addition to regulating the skin’s overall health, cannabinoids also benefit the skin due to their anti-inflammatory and antibacterial qualities.
Topical Application of CBD for Pain Management
Because topical applications of CBD can penetrate as deep as one inch from the surface, topicals containing higher amounts of CBD (5 mg per application) can offer relief from physical pain, arthritis and rheumatism.
As penned by the National Institute of Health, “In the skin, cannabinoid lipids, whether of endogenous or exogenous origin, are capable of regulating numerous sensory, homeostatic, and inflammatory events.” ²
Our topical formulations were developed with the well-being of your skin in mind. We have enhanced a powerful combination of herbs and essential oils with the highest quality CBD to offer you the best CBD topicals available.
Here is to your skin’s best health.
¹ M.Pucci, C. Rapino,A. Di Francesco, E. Dainese, C. D’Addario, and M. Maccarone, “Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids,” British Journal of Pharmacology 170, no.3 (2013): 581.doi:10.1111/bph.12309
